Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. CommentarySTAESSEN, Jan A; JIGUANG WANG.Lancet (British edition). 2001, Vol 358, Num 9287, pp 1026-1027, issn 0140-6736, 11 p.Article

Nouveaux marqueurs tensionnels du risque vasculaire cérébral chez le sujet âgé: L'hypertension artérielle systolique et la pression pulsée = Neurologic risk factor markers in elderly hypertensionSTAESSEN, Jan A.Archives des maladies du coeur et des vaisseaux. Pratique. 2001, Num JUI, pp 4-6, issn 1261-694X, NSConference Paper

A plea for harmonising guidelinesO'BRIEN, Eoin; STAESSEN, Jan A.International journal of cardiology. 2001, Vol 79, Num 2-3, pp 129-132, issn 0167-5273Article

Oral renin inhibitorsSTAESSEN, Jan A; YAN LI; RICHART, Tom et al.Lancet (British edition). 2006, Vol 368, Num 9545, pp 1449-1456, issn 0140-6736, 8 p.Article

Relationships of heart rate and heart rate variability with conventional and ambulatory blood pressure in the populationFAGARD, Robert H; PARDAENS, Karel; STAESSEN, Jan A et al.Journal of hypertension. 2001, Vol 19, Num 3, pp 389-397, issn 0263-6352Article

Benefits of antihypertensive drug treatment in elderly patients with isolated systolic hypertensionWANG, Ji-Guang; STAESSEN, Jan A.Netherlands journal of medicine. 2001, Vol 58, Num 6, pp 248-254, issn 0300-2977Conference Paper

Of fads, fashion, surrogate endpoints and dual RAS blockadeMESSERLI, Franz H; STAESSEN, Jan A; ZANNAD, Faiez et al.European heart journal. 2010, Vol 31, Num 18, pp 2205-2208, issn 0195-668X, 4 p.Article

Adducin polymorphism : Detection and impact on hypertension and related disordersBIANCHI, Giuseppe; FERRARI, Patrizia; STAESSEN, Jan A et al.Hypertension (Dallas, Tex. 1979). 2005, Vol 45, Num 3, pp 331-340, issn 0194-911X, 10 p.Article

The effects of antihypertensive therapy in older patients with white coat and with sustained systolic hypertensionFAGARD, Robert H; STAESSEN, Jan A.Cardiovascular reviews & reports. 2001, Vol 22, Num 8, pp 459-463, issn 0197-3118Article

Design of the Syst-Eur trial and Syst-Eur phase 2: Thomas Weihrauch's contributionsBIRKENHÄGER, Willem H; STAESSEN, Jan A; ZANCHETTI, Alberto et al.Journal of hypertension. 2004, Vol 22, Num 8, pp 1631-1632, issn 0263-6352, 2 p.Article

Raised concentrations of serum creatinine and uric acid and the risks of mortality and cardiovascular diseaseWANG, Ji-Guang; STAESSEN, Jan A.Cardiovascular reviews & reports. 2002, Vol 23, Num 7, pp 393-399, issn 0197-3118, 402 [8 p.]Article

Renal versus extrarenal activation of vitamin D in relation to atherosclerosis, arterial stiffening, and hypertensionRICHART, Tom; YAN LI; STAESSEN, Jan A et al.American journal of hypertension. 2007, Vol 20, Num 9, pp 1007-1015, issn 0895-7061, 9 p.Article

Blood pressure lowering for primary and secondary prevention of strokeHAIFENG ZHANG; THIJS, Lutgarde; STAESSEN, Jan A et al.Hypertension (Dallas, Tex. 1979). 2006, Vol 48, Num 2, pp 187-195, issn 0194-911X, 9 p.Article

Improved outcomes with antihypertensive medication in the Elderly with isolated Systolic HypertensionWANG, Ji-Guang; STAESSEN, Jan A.Drugs & aging. 2001, Vol 18, Num 5, pp 345-353, issn 1170-229XArticle

Cardiovascular protection and blood pressure reduction: a meta-analysisSTAESSEN, Jan A; WANG, Ji-Guang; THIJS, Lutgarde et al.Lancet (British edition). 2001, Vol 358, Num 9290, pp 1305-1315, issn 0140-6736Article

Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brainSTAESSEN, Jan A; RICHART, Tom; BIRKENHÄGER, Willem H et al.Hypertension (Dallas, Tex. 1979). 2007, Vol 49, Num 3, pp 389-400, issn 0194-911X, 12 p.Article

Safety of calcium antagonists : More ACTIONMESSERLI, Franz H; STAESSEN, Jan A.The American journal of medicine. 2005, Vol 118, Num 12, pp 1418-1420, issn 0002-9343, 3 p.Article

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003STAESSEN, Jan A; WANG, Ji-Guang; THIJS, Lutgarde et al.Journal of hypertension. 2003, Vol 21, Num 6, pp 1055-1076, issn 0263-6352, 22 p.Article

Renal Denervation: Ultima Ratio or Standard in Treatment-Resistant HypertensionPERSU, Alexandre; RENKIN, Jean; THIJS, Lutgarde et al.Hypertension (Dallas, Tex. 1979). 2012, Vol 60, Num 3, pp 596-606, issn 0194-911X, 11 p.Article

Conventional therapy and newer drug classes for cardiovascular protection in hypertensionWANG, Ji-Guang; STAESSEN, Jan A.Journal of the American Society of Nephrology. 2002, Vol 13, Num 11, pp 208-215, issn 1046-6673, 8 p., SUP3Conference Paper

Subgroup analysis of the NORDIL trialTHIJS, Lutgarde; STAESSEN, Jan A; JIGUANG WANG et al.Journal of hypertension. 2002, Vol 20, Num 6, pp 1085-1087, issn 0263-6352Article

The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertensionFAGARD, Robert H; PARDAENS, Karel; STAESSEN, Jan A et al.Journal of the American College of Cardiology. 2001, Vol 38, Num 1, pp 227-231, issn 0735-1097Article

Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction : Genetic and protein markers of CVDKUZNETSOVA, Tatiana; MISCHAK, Harald; MULLEN, William et al.European heart journal. 2012, Vol 33, Num 18, pp 2342-2350, issn 0195-668X, 9 p.Article

Outcome beyond blood pressure control?STAESSEN, Jan A; WANG, Ji-Guang; BIRKENHÄGER, Willem H et al.European heart journal. 2003, Vol 24, Num 6, pp 504-514, issn 0195-668X, 11 p.Article

Implications of Recently Published Trials of Blood Pressure―Lowering Drugs in Hypertensive or High-Risk PatientsSTAESSEN, Jan A; RICHART, Tom; ZENGWU WANG et al.Hypertension (Dallas, Tex. 1979). 2010, Vol 55, Num 4, pp 819-831, issn 0194-911X, 13 p.Article